ArticleBMC cancer2026

Preclinical evaluation of a fluorinated bifendate derivative in triple-negative breast cancer: integrated in vitro and in vivo evidence of antitumor activity.

Lisa Zongyong Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.